Skip to content
10-K

Annual Report

VIROPHARMA INC

0001047469-13-001835

← back to feed
Filed
Feb 27, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Feb 15, 2013 65.21M sh
Shares Diluted FY 2012 · Dec 31, 2012 71.76M sh
Shares Diluted FY 2012 · Dec 31, 2011 88.08M sh
Shares Diluted FY 2012 · Dec 31, 2010 90.08M sh
Stock Repurchased FY 2012 · Dec 31, 2012 $180.34M
Stock Repurchased FY 2012 · Dec 31, 2011 $169.66M
Capex FY 2012 · Dec 31, 2012 $1.33M
Capex FY 2012 · Dec 31, 2011 $3.01M
Capex FY 2012 · Dec 31, 2010 $2.81M
Cash And Equivalents FY 2012 · Dec 31, 2012 $175.52M
Cash And Equivalents FY 2012 · Dec 31, 2011 $331.35M
Cash And Equivalents FY 2012 · Dec 31, 2010 $426.73M
Cash And Equivalents FY 2012 · Dec 31, 2009 $331.67M
Stockholders Equity FY 2012 · Dec 31, 2012 $757.04M
Stockholders Equity FY 2012 · Dec 31, 2011 $891.12M
Stockholders Equity FY 2012 · Dec 31, 2010 $891.14M
Stockholders Equity FY 2012 · Dec 31, 2009 $750.39M
Current Liabilities FY 2012 · Dec 31, 2012 $114.03M
Current Liabilities FY 2012 · Dec 31, 2011 $98.65M
Total Liabilities FY 2012 · Dec 31, 2012 $462.91M
Total Liabilities FY 2012 · Dec 31, 2011 $445.67M
Current Assets FY 2012 · Dec 31, 2012 $453.42M
Current Assets FY 2012 · Dec 31, 2011 $635.93M
Total Assets FY 2012 · Dec 31, 2012 $1.22B
Total Assets FY 2012 · Dec 31, 2011 $1.34B
Eps Diluted FY 2012 · Dec 31, 2012 −$0.06
Eps Diluted FY 2012 · Dec 31, 2012 $0.08
Eps Diluted FY 2012 · Sep 30, 2012 −$0.07
Eps Diluted FY 2012 · Jun 30, 2012 −$0.08
Eps Diluted FY 2012 · Mar 31, 2012 $0.26
Eps Diluted FY 2012 · Dec 31, 2011 $0.65
Eps Diluted FY 2012 · Dec 31, 2011 $1.68
Eps Diluted FY 2012 · Sep 30, 2011 $0.35
Eps Diluted FY 2012 · Jun 30, 2011 $0.28
Eps Diluted FY 2012 · Mar 31, 2011 $0.40
Eps Diluted FY 2012 · Dec 31, 2010 $1.47
Eps Basic FY 2012 · Dec 31, 2012 −$0.06
Eps Basic FY 2012 · Dec 31, 2012 $0.08
Eps Basic FY 2012 · Sep 30, 2012 −$0.07
Eps Basic FY 2012 · Jun 30, 2012 −$0.08
Eps Basic FY 2012 · Mar 31, 2012 $0.28
Eps Basic FY 2012 · Dec 31, 2011 $0.75
Eps Basic FY 2012 · Dec 31, 2011 $1.89
Eps Basic FY 2012 · Sep 30, 2011 $0.38
Eps Basic FY 2012 · Jun 30, 2011 $0.30
Eps Basic FY 2012 · Mar 31, 2011 $0.47
Eps Basic FY 2012 · Dec 31, 2010 $1.61
Sga Expense FY 2012 · Dec 31, 2012 $174.32M
Sga Expense FY 2012 · Dec 31, 2011 $127.78M
Sga Expense FY 2012 · Dec 31, 2010 $95.66M
Rd Expense FY 2012 · Dec 31, 2012 $67.71M
Rd Expense FY 2012 · Dec 31, 2011 $66.48M
Rd Expense FY 2012 · Dec 31, 2010 $39.61M
Operating Income FY 2012 · Dec 31, 2012 $33.34M
Operating Income FY 2012 · Dec 31, 2011 $222.13M
Operating Income FY 2012 · Dec 31, 2010 $211.7M
Cost Of Revenue FY 2012 · Dec 31, 2012 $26.83M
Cost Of Revenue FY 2012 · Dec 31, 2012 $108.55M
Cost Of Revenue FY 2012 · Sep 30, 2012 $21.55M
Cost Of Revenue FY 2012 · Jun 30, 2012 $28.09M
Cost Of Revenue FY 2012 · Mar 31, 2012 $32.08M
Cost Of Revenue FY 2012 · Dec 31, 2011 $19.68M
Cost Of Revenue FY 2012 · Dec 31, 2011 $79.98M
Cost Of Revenue FY 2012 · Sep 30, 2011 $20.12M
Cost Of Revenue FY 2012 · Jun 30, 2011 $21.31M
Cost Of Revenue FY 2012 · Mar 31, 2011 $18.87M
Cost Of Revenue FY 2012 · Dec 31, 2010 $61.29M